Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Replacement for SUI in Postmenopausal Women
NCT03116087Completed
- Sponsor
- Charles Drew University of Medicine & Science
- Start
- Mar 2007
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Testosterone TEPI patch in stress urinary incontinence (SUI) (2 arms), sponsored by Charles Drew University of Medicine & Science. Primary endpoint: Change in levator ani muscle volume at 36 weeks. Started Mar 2007; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT03116087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03116087.